Clinical Trial Update: A Study to Assess Adverse Events and Effectiveness of Intradermally Injected JUVÉDERM® VOLITE™ Gel Filler in Adult Participants For the Improvement of Skin Quality [Phase 2, Phase 3]

View source ↗

Summary

This clinical trial update reports adverse events and effectiveness data from Phase 2 and Phase 3 studies evaluating intradermal JUVÉDERM VOLITE Gel Filler for …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Skin Quality Deficit

Drugs mentioned

• JUVÉDERM VOLITE Gel Filler (hyaluronic acid gel filler)

Snippet

Sponsor: AbbVie | Conditions: Skin Quality Deficit | Phase 2, Phase 3 | Status: COMPLETED